Exosomes Market
Exosomes Market Forecasts to 2030 - Global Analysis By Product (Exosome Isolation Kits, Exosome Detection and Characterization Kits and Other Products), Source, Technique, End User and By Geography
According to Stratistics MRC, the Global Exosomes Market is accounted for $177.4 million in 2024 and is expected to reach $884.31 million by 2030 growing at a CAGR of 30.7% during the forecast period. Exosomes are tiny, membrane-bound extracellular vesicles secreted by various cell types into bodily fluids. Typically 30-150 nanometres in diameter, they carry bioactive molecules such as proteins, lipids, and nucleic acids, serving as intercellular communication vehicles. Exosomes play crucial roles in physiological processes, including immune responses and tissue repair, as well as pathological conditions like cancer, neurodegenerative diseases, and infections. Their unique properties have made them a focus in diagnostics and therapeutic delivery systems, offering potential for precision medicine applications.
According to the American Cancer Society, an estimated 1.9 million new cancer cases and 609,360 cancer deaths were recorded by the end of 2022.
Market Dynamics:
Driver:
Growing applications in drug delivery
Exosomes serve as natural carriers for targeted drug delivery, offering high biocompatibility and low immunogenicity. Their ability to encapsulate therapeutic molecules, such as RNA, proteins, and small drugs, enhances treatment efficacy. Moreover, advancements in engineering exosomes to improve drug-loading capacity and targeting precision have fuelled their adoption. Pharmaceutical companies are increasingly investing in exosome-based drug delivery systems, recognizing their potential for precision medicine. This trend is expected to significantly boost market growth in the coming years.
Restraint:
High cost of research and development
Developing exosome-based therapies and diagnostics requires substantial investment in advanced technologies, clinical trials, and regulatory approvals. These expenses often limit the ability of smaller companies and startups to enter the market. Moreover, the long development timeline increases financial risks, discouraging potential investors. High R&D costs also lead to increased prices for end products, making them less accessible to healthcare providers and patients. Consequently, the overall growth and widespread adoption of exosome-based innovations face considerable delays and obstacles.
Opportunity:
Therapeutic potential in rare diseases
Exosomes act as natural carriers for focused providing novel solutions for diseases, drug delivery with few therapy alternatives. Their capacity to traverse biological barriers, such as the blood-brain barrier, increases their usefulness in treating complex uncommon diseases. Furthermore, advances in exosome isolation and engineering have permitted the development of targeted medicines. Growing interest in personalized medicine and orphan drug development further propels research and investment in this field. Consequently, the exosome market is witnessing robust expansion due to its transformative potential in treating rare diseases.
Threat:
Intellectual property disputes
Patent conflicts can delay the development and commercialization of new exosome-based therapies and diagnostic tools. Companies involved in litigation often face increased legal costs, diverting resources from research and development. IP disputes can also lead to exclusivity in the market, limiting competition and driving up prices. Smaller firms may struggle to enter the market due to patent protections held by larger players. Overall, these disputes slow down the growth and accessibility of exosome-based products and services.
Covid-19 Impact
The COVID-19 pandemic positively impacted the exosomes market. The pandemic prompted an unprecedented surge in research efforts to understand the virus. Exosomes, being small vesicles involved in cell communication, were studied to better understand the virus's mechanisms of infection and its effects on host cells. This led to increased demand for exosome-related research tools and diagnostics for studying COVID-19. Additionally, several COVID-19 vaccines were developed and authorized for emergency use during the pandemic.
The exosome isolation kits segment is expected to be the largest during the forecast period
The exosome isolation kits segment is estimated to have a lucrative growth, due to the efficient and reliable methods for isolating exosomes from various biological samples. These kits enable researchers to extract high-quality exosomes, essential for downstream applications such as diagnostics and therapeutics. With increasing demand for non-invasive diagnostic methods, these kits support liquid biopsy advancements, a key growth area. Moreover, the growing emphasis on personalized medicine further drives the need for precise exosome isolation tools. As a result, the exosome isolation kit segment contributes significantly to market expansion by enhancing the accuracy and scope of exosome-related research and applications.
The diagnostic laboratories segment is expected to have the highest CAGR during the forecast period
The diagnostic laboratories segment is anticipated to witness the highest CAGR growth during the forecast period, by leveraging their potential in non-invasive diagnostics. Exosomes contain biomarkers like proteins, lipids, and nucleic acids that aid in detecting diseases at an early stage. These laboratories utilize advanced technologies to isolate and analyze exosomes, enabling precise diagnosis of cancer, neurodegenerative disorders, and cardiovascular diseases. Collaborations between labs and biotech firms enhance the development of innovative exosome-based diagnostic tools. As awareness of exosome applications grows, diagnostic laboratories are becoming pivotal in expanding the exosomes market globally.
Region with largest share:
Asia Pacific is expected to hold the largest market share during the forecast period due to increased applications of exosomes in diagnostics, therapeutics, and drug delivery. Advances in biotechnology and the growing focus on personalized medicine are key drivers. Countries like China, Japan, and India are witnessing rapid advancements in exosome-based research and commercialization. The demand for non-invasive diagnostic techniques and the rising prevalence of diseases such as cancer and neurodegenerative disorders are further fuelling market expansion. Additionally, the presence of a robust healthcare infrastructure and increasing investments are boosting market opportunities in this region.
Region with highest CAGR:
North America is expected to have the highest CAGR over the forecast period, owing to advancements in biotechnology, increasing research in regenerative medicine, and rising demand for personalized therapies. Exosomes, as carriers of RNA, proteins, and lipids, are crucial in diagnostics and drug delivery systems. The market is benefiting from the expanding applications in cancer treatment, neurological disorders, and immunotherapy. Additionally, robust support from research institutions and healthcare funding in the U.S. and Canada is propelling innovation.
Key players in the market
Some of the key players profiled in the Exosomes Market include Evox Therapeutics, Capricor Therapeutics, EXO Biologics, Aethlon Medical, Coya Therapeutics, Aegle Therapeutics Corporation, Aragen Bioscience, RoosterBio, Inc., Bio-Techne, Thermo Fisher Scientific, Inc., Danaher and Hologic Inc.
Key Developments:
In June 2024, EXO Biologics announced ongoing partnerships with multiple entities in Europe and the US, emphasizing their strategy to license the ExoPulse platform to accelerate drug development. This approach allows EXO Biologics to focus on direct drug development while enabling ExoXpert to support other companies through licensing agreements.
In April 2024, ExoXpert, a subsidiary of EXO Biologics, entered a strategic partnership with Neucore Bio. This collaboration focuses on evaluating advanced exosome loading using ExoXpert's ExoPulse platform to optimize the delivery of proprietary payloads into exosomes.
In July 2023, Evox completed the acquisition of Codiak Biosciences’ engEx-AAV™ technology platform. This acquisition includes all intellectual property rights associated with the technology, which facilitates the active loading of adeno-associated virus (AAV) into exosomes, thereby improving delivery efficacy and shielding AAVs from neutralizing antibodies
Products Covered:
• Exosome Isolation Kits
• Exosome Detection and Characterization Kits
• Exosome Therapeutics
• Exosome Diagnostic Kits
• Other Products
Sources Covered:
• Human-Derived Exosomes
• Animal-Derived Exosomes
• Plant-Derived Exosomes
Techniques Covered:
• Exosome Isolation Techniques
• Exosome Characterization Techniques
End Users Covered:
• Pharmaceutical and Biopharmaceutical Companies
• Academic and Research Institutes
• Diagnostic Laboratories
• Contract Research Organizations (CROs)
• Hospitals and Clinics
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Exosomes Market, By Product
5.1 Introduction
5.2 Exosome Isolation Kits
5.3 Exosome Detection and Characterization Kits
5.4 Exosome Therapeutics
5.5 Exosome Diagnostic Kits
5.6 Other Products
6 Global Exosomes Market, By Source
6.1 Introduction
6.2 Human-Derived Exosomes
6.3 Animal-Derived Exosomes
6.4 Plant-Derived Exosomes
7 Global Exosomes Market, By Technique
7.1 Introduction
7.2 Exosome Isolation Techniques
7.2.1 Ultracentrifugation
7.2.2 Size Exclusion Chromatography (SEC)
7.2.3 Immunoaffinity Capture
7.2.4 Precipitation-Based Techniques
7.2.5 Microfluidic Technology
7.3 Exosome Characterization Techniques
7.3.1 Nanoparticle Tracking Analysis (NTA)
7.3.2 Electron Microscopy (EM)
7.3.3 Western Blotting
7.3.4 Flow Cytometry
7.3.5 Enzyme-Linked Immunosorbent Assay (ELISA)
8 Global Exosomes Market, By End User
8.1 Introduction
8.2 Pharmaceutical and Biopharmaceutical Companies
8.3 Academic and Research Institutes
8.4 Diagnostic Laboratories
8.5 Contract Research Organizations (CROs)
8.6 Hospitals and Clinics
8.7 Other End Users
9 Global Exosomes Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Evox Therapeutics
11.2 Capricor Therapeutics
11.3 EXO Biologics
11.4 Aethlon Medical
11.5 Coya Therapeutics
11.6 Aegle Therapeutics Corporation
11.7 Aragen Bioscience
11.8 RoosterBio, Inc.
11.9 Bio-Techne
11.10 Thermo Fisher Scientific, Inc.
11.11 Danaher
11.12 Hologic Inc.
List of Tables
1 Global Exosomes Market Outlook, By Region (2022-2030) ($MN)
2 Global Exosomes Market Outlook, By Product (2022-2030) ($MN)
3 Global Exosomes Market Outlook, By Exosome Isolation Kits (2022-2030) ($MN)
4 Global Exosomes Market Outlook, By Exosome Detection and Characterization Kits (2022-2030) ($MN)
5 Global Exosomes Market Outlook, By Exosome Therapeutics (2022-2030) ($MN)
6 Global Exosomes Market Outlook, By Exosome Diagnostic Kits (2022-2030) ($MN)
7 Global Exosomes Market Outlook, By Other Products (2022-2030) ($MN)
8 Global Exosomes Market Outlook, By Source (2022-2030) ($MN)
9 Global Exosomes Market Outlook, By Human-Derived Exosomes (2022-2030) ($MN)
10 Global Exosomes Market Outlook, By Animal-Derived Exosomes (2022-2030) ($MN)
11 Global Exosomes Market Outlook, By Plant-Derived Exosomes (2022-2030) ($MN)
12 Global Exosomes Market Outlook, By Technique (2022-2030) ($MN)
13 Global Exosomes Market Outlook, By Exosome Isolation Techniques (2022-2030) ($MN)
14 Global Exosomes Market Outlook, By Ultracentrifugation (2022-2030) ($MN)
15 Global Exosomes Market Outlook, By Size Exclusion Chromatography (SEC) (2022-2030) ($MN)
16 Global Exosomes Market Outlook, By Immunoaffinity Capture (2022-2030) ($MN)
17 Global Exosomes Market Outlook, By Precipitation-Based Techniques (2022-2030) ($MN)
18 Global Exosomes Market Outlook, By Microfluidic Technology (2022-2030) ($MN)
19 Global Exosomes Market Outlook, By Exosome Characterization Techniques (2022-2030) ($MN)
20 Global Exosomes Market Outlook, By Nanoparticle Tracking Analysis (NTA) (2022-2030) ($MN)
21 Global Exosomes Market Outlook, By Electron Microscopy (EM) (2022-2030) ($MN)
22 Global Exosomes Market Outlook, By Western Blotting (2022-2030) ($MN)
23 Global Exosomes Market Outlook, By Flow Cytometry (2022-2030) ($MN)
24 Global Exosomes Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2022-2030) ($MN)
25 Global Exosomes Market Outlook, By End User (2022-2030) ($MN)
26 Global Exosomes Market Outlook, By Pharmaceutical and Biopharmaceutical Companies (2022-2030) ($MN)
27 Global Exosomes Market Outlook, By Academic and Research Institutes (2022-2030) ($MN)
28 Global Exosomes Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
29 Global Exosomes Market Outlook, By Contract Research Organizations (CROs) (2022-2030) ($MN)
30 Global Exosomes Market Outlook, By Hospitals and Clinics (2022-2030) ($MN)
31 Global Exosomes Market Outlook, By Other End Users (2022-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
